<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
 <url>
  <loc>https://www.medipharmhealth.co.kr/news/article.html?no=115308</loc>
  <news:news>
   <news:publication>
    <news:name>메디팜헬스뉴스</news:name>
    <news:language>ko</news:language>
   </news:publication>
   <news:genres>PressRelease</news:genres>
   <news:publication_date>2026-04-05T07:18:20+09:00</news:publication_date>
   <news:title>한독 ‘엑스페인정’, 니트로사민 불순물 기준 초과…식약처, 회수 조치</news:title>
   <news:keywords>메디팜헬스뉴스, 제약회사, 한독 ‘엑스페인정’, 니트로사민 불순물 기준 초과…식약처, 회수 조치</news:keywords>
  </news:news>
 </url>
 <url>
  <loc>https://www.medipharmhealth.co.kr/news/article.html?no=115307</loc>
  <news:news>
   <news:publication>
    <news:name>메디팜헬스뉴스</news:name>
    <news:language>ko</news:language>
   </news:publication>
   <news:genres>PressRelease</news:genres>
   <news:publication_date>2026-04-05T07:06:44+09:00</news:publication_date>
   <news:title>부광약품 공장에 무슨일이... ‘부광미다졸람주사’, 포장 표시 오류로 회수 조치</news:title>
   <news:keywords>메디팜헬스뉴스, 기본분류, 부광약품 공장에 무슨일이... ‘부광미다졸람주사’, 포장 표시 오류로 회수 조치</news:keywords>
  </news:news>
 </url>
 <url>
  <loc>https://www.medipharmhealth.co.kr/news/article.html?no=115306</loc>
  <news:news>
   <news:publication>
    <news:name>메디팜헬스뉴스</news:name>
    <news:language>ko</news:language>
   </news:publication>
   <news:genres>PressRelease</news:genres>
   <news:publication_date>2026-04-05T06:58:41+09:00</news:publication_date>
   <news:title>건일바이오팜, 의약품 식별표시 미변경 위반…식약처,아목크라건정 판매정지 처분</news:title>
   <news:keywords>메디팜헬스뉴스, 제약ㆍ약사, 건일바이오팜, 의약품 식별표시 미변경 위반…식약처,아목크라건정 판매정지 처분</news:keywords>
  </news:news>
 </url>
 <url>
  <loc>https://www.medipharmhealth.co.kr/news/article.html?no=115305</loc>
  <news:news>
   <news:publication>
    <news:name>메디팜헬스뉴스</news:name>
    <news:language>ko</news:language>
   </news:publication>
   <news:genres>PressRelease</news:genres>
   <news:publication_date>2026-04-05T06:51:46+09:00</news:publication_date>
   <news:title>미래바이오제약, 모사드정 등 무더기 제조업무정지 처분…최대 5개월</news:title>
   <news:keywords>메디팜헬스뉴스, 식품의약품안전처, 미래바이오제약, 모사드정 등 무더기 제조업무정지 처분…최대 5개월</news:keywords>
  </news:news>
 </url>
 <url>
  <loc>https://www.medipharmhealth.co.kr/news/article.html?no=115304</loc>
  <news:news>
   <news:publication>
    <news:name>메디팜헬스뉴스</news:name>
    <news:language>ko</news:language>
   </news:publication>
   <news:genres>PressRelease</news:genres>
   <news:publication_date>2026-04-05T06:44:49+09:00</news:publication_date>
   <news:title>이수앱지스, 임상시험계획 변경 미승인 등 위반…임상시험 1개월 업무정지 처분</news:title>
   <news:keywords>메디팜헬스뉴스, 식품의약품안전처, 이수앱지스, 임상시험계획 변경 미승인 등 위반…임상시험 1개월 업무정지 처분</news:keywords>
  </news:news>
 </url>
 <url>
  <loc>https://www.medipharmhealth.co.kr/news/article.html?no=115298</loc>
  <news:news>
   <news:publication>
    <news:name>메디팜헬스뉴스</news:name>
    <news:language>ko</news:language>
   </news:publication>
   <news:genres>PressRelease</news:genres>
   <news:publication_date>2026-04-04T07:48:14+09:00</news:publication_date>
   <news:title>/노재영 칼럼/ 중동발 쇼크, '원료의약품 자급' 더는 미룰 수 없다